EFA granted a reward to digital health technologies that benefit and centre asthma and COPD patients through their design, accessibility and efficacy. A prestigious jury assessed the pillars for a successful tool, as well as the ways in which innovators have included digital collaboration and co-creation approaches between patients, healthcare providers and solutions developers at the core of their work.
EFA is running a project to fill the awareness gap and develop a Consensus among the burden of Atopic Eczema/Dermatitis for Patients.
3TR is an IMI funded project studying the molecular pathways and mechanisms linked to response and non-response to therapy in different immune-mediated, allergic and inflammatory diseases, including asthma and COPD.
The European Atopic Eczema Community will come together on World Atopic Eczema Day 2024 to amplify the voices of those living with atopic eczema through the #AtopicEczemaUnfiltered campaign. The 2024 World Atopic Eczema Day toolkit and resources are now available!
The time is now for a lung health policy that helps Europe to Keep Breathing.
The Breathe Vision for 2030 outlines shared aims by respiratory partners to increase attention towards respiratory health, while also supporting the general awareness and understanding of lung disease in society.
Show your support to the Breathe Vision for 2030!
#ShowLeadership is a pan-European campaign encouraging policymakers, stakeholders and individuals to take action to improve the situation of allergy, asthma and COPD patients in Europe. Only together, change is possible
Severely, ASTHMA! is a video series portraying six severe asthma patients and their families throughout Europe, each bringing a unique insight on diagnosis, care, social and family life, participating in research and living with air pollution.
EFA launched a new report - 'Raising standards of care for chronic obstructive pulmonary disease (COPD)'. The report examines care in 19 European countries, revealing critical gaps in prevention, diagnosis, and treatment and calls for urgent regional policy action to reduce economic and social burden of COPD in Europe.
Discover the 2023 Annual Report: a comprehensive overview of the patients' agenda for allergy and airways diseases.
EFA and The European Lung Health Group call on EU policymakers to address lung health in a new publication. #KeepBreathing: A vision for EU action on lung health 2024-2029
Following one year of in-depth discussions around the reality of Atopic Dermatitis/Eczema (AD/E), the Atopic Eczema Consensus Committee launched their consensus on the struggle of AD/E patients in Europe: ‘The Burden of Atopic Eczema / Dermatitis - European Consensus Report 2022’.
EFA and the Global Allergy and Airways Patients Platform (GAAPP) launched an educational website on asthma for patients and carers – AboutAsthma.org. The website serves as a comprehensive patient guide to asthma and provides science-based information and tips to patients and carers across five areas: asthma symptoms, attacks, care, life with asthma and help.
A survey co-organised by EFA Member Stichting Voedselallergie (Dutch Food Allergies Foundation) shows that hospitals are not always taking care of food allergies of their patients. EFA Board member Erna Botjes talked about the issue on broadcast.
Click here to watch the video.